Why Moderna stock fell 32% in December

Investors in the COVID-19 vaccine maker took some profits last month.

| More on:
A glass jar labelled COVID_19 vaccine sits on a bench with capsules and precriptions drugs.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

What happened

Shares of biotech Moderna (NASDAQ: MRNA), maker of a COVID-19 vaccine, dropped 31.6% in December, according to data from S&P Global Market Intelligence

For context, the S&P 500 Index (INDEXSP: .INX) returned 3.8% last month.

So what

We can attribute Moderna stock's 32% drop last month to profit taking. After all, shares were up a whopping 581% in 2020 through the end of November, so it wasn't surprising that some investors took some money off the table in December. Moderna stock ended the year with a 434% gain.  

Shares of Moderna began their long climb early in 2020 when the company announced that it was developing a vaccine to immunise against COVID-19, the disease caused by the novel coronavirus.

As the below chart shows, the stock had a sharp run-up in November. It skyrocketed 126% in that month, driven by a string of great news about mRNA-1273, which was then a messenger RNA-based vaccine candidate.

On 30 November, Moderna announced the positive final results from its phase 3 study. As I previously wrote, "It found its vaccine candidate to be 94.1% effective in preventing COVID-19, and it uncovered no serious safety concerns. Moreover, the company said that it had submitted a request with the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) for mRNA-1273."

Then on 18 December came "the big news": Moderna announced the FDA had authorised the emergency use of mRNA-1273. Shares, which had been moving downward throughout December, fell nearly 3% that day. The reason shares dropped on such terrific news is that this news was widely expected and already priced in during November.

The US distribution of the vaccine began the next day, and administration of the first of the two-dose vaccine started on 20 December.

MRNA Chart

Data by YCharts.

Now what

On 18 December, Moderna said that it expected to deliver about 20 million doses to the US government by the end of December 2020. It also expects to have between 100 million and 125 million doses available globally in the first quarter of 2021, with 85 to 100 million of those available in the US. A total of 200 million doses was ordered by the US government, which has the option to purchase up to an additional 300 million doses.

The rollout of Moderna's vaccine to the states was slower than anticipated in December, but that's not its fault. The federal government's Operation Warp Speed is in charge of distribution.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 30 April 2025

Beth McKenna has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on International Stock News

Delighted adult man, working on a company slogan, on his laptop.
International Stock News

Prediction: This artificial intelligence (AI) stock will be worth $5 trillion in 5 years

Amazon is integrating artificial intelligence (AI) across many areas of its business.

Read more »

Robot humanoid using artificial intelligence on a laptop.
International Stock News

Google must win at artificial intelligence or its search business could crumble. Does this make Alphabet an AI stock to buy?

Here's a deeper look into how Alphabet is faring in the battle for AI supremacy.

Read more »

A delivery man wearing a cap and smiling broadly delivers two boxes stacked on top of each other at the door of a female customer whose back can be seen at the edge of a doorway.
International Stock News

2 "Magnificent Seven" stocks billionaires are buying

The Magnificent Seven includes some of the most profitable and dominant tech companies in the world.

Read more »

Happy man working on his laptop.
International Stock News

Prediction: This artificial intelligence (AI) stock will be the biggest winner of 2025

Artificial intelligence will be one of the biggest growth opportunities this century.

Read more »

Legendary share market investing expert and owner of Berkshire Hathaway Warren Buffett
International Stock News

Could Warren Buffett's last move as Berkshire Hathaway CEO be buying this beaten-down "Magnificent Seven" stock?

Buffett is a value investor at his core, and he doesn't often buy shares of expensive companies.

Read more »

A woman holds a soldering tool as she sits in front of a computer screen while working on the manufacturing of technology equipment in a laboratory environment.
International Stock News

Prediction: This artificial intelligence (AI) stock will be worth $5 trillion in 3 years

Let's take a closer look at the catalysts that could propel this stock toward that valuation.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
International Stock News

This Artificial Intelligence (AI) chipmaker just got a game-changing boost from Amazon, and Nvidia investors should be paying close attention

Amazon just made a notable investment in Nvidia's top rival.

Read more »

Happy man working on his laptop.
International Stock News

A once-in-a-decade opportunity: Here's why I'm buying Alphabet stock like there's no tomorrow

Alphabet's stock rarely gets this cheap, and right now could be a once-in-a-decade opportunity to scoop up shares at a…

Read more »